Development of a high-throughput RT-PCR based viral infectivity assay for monitoring the stability of a replicating recombinant Lymphocytic Choriomeningitis viral vector

•Development of a RT-qPCR-based infectivity assay for a live, recombinant replicating lymphocytic choriomeningitis virus (LCMV) viral vector.•A high positive correlation between the RT-qPCR and the “gold-standard” infectivity assays.•The infectivity RT-qPCR assay demonstrated increased sample throug...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of virological methods 2022-03, Vol.301, p.114440-114440, Article 114440
Hauptverfasser: Gupta, Vineet, Antunez, Lorena R., Saleh-Birdjandi, Soraia, Kumru, Ozan S., Pospisil, Richard, Lilja, Anders, Fuhrmann, Gerhard, Smith, Lee, Volkin, David B., Joshi, Sangeeta B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 114440
container_issue
container_start_page 114440
container_title Journal of virological methods
container_volume 301
creator Gupta, Vineet
Antunez, Lorena R.
Saleh-Birdjandi, Soraia
Kumru, Ozan S.
Pospisil, Richard
Lilja, Anders
Fuhrmann, Gerhard
Smith, Lee
Volkin, David B.
Joshi, Sangeeta B.
description •Development of a RT-qPCR-based infectivity assay for a live, recombinant replicating lymphocytic choriomeningitis virus (LCMV) viral vector.•A high positive correlation between the RT-qPCR and the “gold-standard” infectivity assays.•The infectivity RT-qPCR assay demonstrated increased sample throughput and improved assay flexibility.•The RT-qPCR assay can potentially be utilized as an in-process monitoring tool during LCMV vector manufacturing. Traditional virus infectivity titration methods for lymphocytic choriomeningitis virus (LCMV) are laborious, time-consuming, and low-throughput (e.g., focus forming unit (FFA) assay). In this report, we developed a high-throughput reverse transcription quantitative PCR (RT-qPCR)-based virus infectivity assay for relative quantitation of a live, recombinant replicating LCMV -based viral vector (TT1). This in vitro infectivity assay demonstrated a 4-log linear range for TT1 titer quantitation. A high positive Pearson correlation coefficient value (≥ 0.80) was obtained between the RT-qPCR vs. the “gold-standard” FFU assay when comparing the stability profiles of stressed TT1 vector samples. In addition to the RT-qPCR infectivity assay, the stability of the TT1 vector upon freeze-thaw stress was investigated further with complementary viral particle characterization techniques (e.g., TEM, NTA, MFI). Correlations between viral infectivity and particle measurements during forced degradation studies were observed to be specific to the TT1 vector and its various formulations and such results facilitated the rank-ordering of formulation conditions. Overall, this infectivity RT-qPCR method showed increased sample throughput and improved assay flexibility compared to traditional viral infectivity assays. These results are discussed in the context of enabling future TT1 vector formulation development work, and potential utilization as an in-process monitoring tool during TT1 vector manufacturing.
doi_str_mv 10.1016/j.jviromet.2021.114440
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2614759592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166093421003797</els_id><sourcerecordid>2614759592</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-53463dc4b2efc6931c43fa17f1252aee5e1faa8e7ef175f3e3c928b60c41b2263</originalsourceid><addsrcrecordid>eNqFkcuO0zAUhi0EYjoDrzDykk2Kb3GaHahcpUqg0bC2HOe4cZXEwXYi5ZHmLXFphy0rW_L3n0_HP0L3lGwpofL9aXtaXPADpC0jjG4pFUKQF2hDd1VdkHonXqJNBmW-c3GDbmM8EULKivPX6IaLuhScyA16-gQL9H4aYEzYW6xx545dkbrg52M3zQk_PBY_9w-40RFanJ26x260YJJbXFqxjlGv2PqABz-65IMbjzh1gGPSjevPyN-xAabeGZ3OzwGMHxo36uw8rMPUebMmZ_C-y_G805ghl1y86pYs8-ENemV1H-Ht9bxDv758ftx_Kw4_vn7ffzwURlCZipILyVsjGgbWyJpTI7jVtLKUlUwDlECt1juowNKqtBy4qdmukSTHG8Ykv0PvLnOn4H_PEJMaXDTQ93oEP0fFJBVVWZc1y6i8oCb4GANYNQU36LAqStS5JnVSzzWpc03qUlMO3l8dczNA-y_23EsGPlwAyJsuDoKKxsFooHX585Jqvfuf4w9grqxX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2614759592</pqid></control><display><type>article</type><title>Development of a high-throughput RT-PCR based viral infectivity assay for monitoring the stability of a replicating recombinant Lymphocytic Choriomeningitis viral vector</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Gupta, Vineet ; Antunez, Lorena R. ; Saleh-Birdjandi, Soraia ; Kumru, Ozan S. ; Pospisil, Richard ; Lilja, Anders ; Fuhrmann, Gerhard ; Smith, Lee ; Volkin, David B. ; Joshi, Sangeeta B.</creator><creatorcontrib>Gupta, Vineet ; Antunez, Lorena R. ; Saleh-Birdjandi, Soraia ; Kumru, Ozan S. ; Pospisil, Richard ; Lilja, Anders ; Fuhrmann, Gerhard ; Smith, Lee ; Volkin, David B. ; Joshi, Sangeeta B.</creatorcontrib><description>•Development of a RT-qPCR-based infectivity assay for a live, recombinant replicating lymphocytic choriomeningitis virus (LCMV) viral vector.•A high positive correlation between the RT-qPCR and the “gold-standard” infectivity assays.•The infectivity RT-qPCR assay demonstrated increased sample throughput and improved assay flexibility.•The RT-qPCR assay can potentially be utilized as an in-process monitoring tool during LCMV vector manufacturing. Traditional virus infectivity titration methods for lymphocytic choriomeningitis virus (LCMV) are laborious, time-consuming, and low-throughput (e.g., focus forming unit (FFA) assay). In this report, we developed a high-throughput reverse transcription quantitative PCR (RT-qPCR)-based virus infectivity assay for relative quantitation of a live, recombinant replicating LCMV -based viral vector (TT1). This in vitro infectivity assay demonstrated a 4-log linear range for TT1 titer quantitation. A high positive Pearson correlation coefficient value (≥ 0.80) was obtained between the RT-qPCR vs. the “gold-standard” FFU assay when comparing the stability profiles of stressed TT1 vector samples. In addition to the RT-qPCR infectivity assay, the stability of the TT1 vector upon freeze-thaw stress was investigated further with complementary viral particle characterization techniques (e.g., TEM, NTA, MFI). Correlations between viral infectivity and particle measurements during forced degradation studies were observed to be specific to the TT1 vector and its various formulations and such results facilitated the rank-ordering of formulation conditions. Overall, this infectivity RT-qPCR method showed increased sample throughput and improved assay flexibility compared to traditional viral infectivity assays. These results are discussed in the context of enabling future TT1 vector formulation development work, and potential utilization as an in-process monitoring tool during TT1 vector manufacturing.</description><identifier>ISSN: 0166-0934</identifier><identifier>EISSN: 1879-0984</identifier><identifier>DOI: 10.1016/j.jviromet.2021.114440</identifier><identifier>PMID: 34954306</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Focus forming unit (FFU) ; Formulation ; Replicating recombinant lymphocytic choriomeningitis virus (TT1) ; Reverse transcription quantitative PCR (RT-qPCR) ; Stability ; Viral vector</subject><ispartof>Journal of virological methods, 2022-03, Vol.301, p.114440-114440, Article 114440</ispartof><rights>2021</rights><rights>Copyright © 2021. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-53463dc4b2efc6931c43fa17f1252aee5e1faa8e7ef175f3e3c928b60c41b2263</citedby><cites>FETCH-LOGICAL-c416t-53463dc4b2efc6931c43fa17f1252aee5e1faa8e7ef175f3e3c928b60c41b2263</cites><orcidid>0000-0002-3494-550X ; 0000-0002-1448-1998</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jviromet.2021.114440$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34954306$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gupta, Vineet</creatorcontrib><creatorcontrib>Antunez, Lorena R.</creatorcontrib><creatorcontrib>Saleh-Birdjandi, Soraia</creatorcontrib><creatorcontrib>Kumru, Ozan S.</creatorcontrib><creatorcontrib>Pospisil, Richard</creatorcontrib><creatorcontrib>Lilja, Anders</creatorcontrib><creatorcontrib>Fuhrmann, Gerhard</creatorcontrib><creatorcontrib>Smith, Lee</creatorcontrib><creatorcontrib>Volkin, David B.</creatorcontrib><creatorcontrib>Joshi, Sangeeta B.</creatorcontrib><title>Development of a high-throughput RT-PCR based viral infectivity assay for monitoring the stability of a replicating recombinant Lymphocytic Choriomeningitis viral vector</title><title>Journal of virological methods</title><addtitle>J Virol Methods</addtitle><description>•Development of a RT-qPCR-based infectivity assay for a live, recombinant replicating lymphocytic choriomeningitis virus (LCMV) viral vector.•A high positive correlation between the RT-qPCR and the “gold-standard” infectivity assays.•The infectivity RT-qPCR assay demonstrated increased sample throughput and improved assay flexibility.•The RT-qPCR assay can potentially be utilized as an in-process monitoring tool during LCMV vector manufacturing. Traditional virus infectivity titration methods for lymphocytic choriomeningitis virus (LCMV) are laborious, time-consuming, and low-throughput (e.g., focus forming unit (FFA) assay). In this report, we developed a high-throughput reverse transcription quantitative PCR (RT-qPCR)-based virus infectivity assay for relative quantitation of a live, recombinant replicating LCMV -based viral vector (TT1). This in vitro infectivity assay demonstrated a 4-log linear range for TT1 titer quantitation. A high positive Pearson correlation coefficient value (≥ 0.80) was obtained between the RT-qPCR vs. the “gold-standard” FFU assay when comparing the stability profiles of stressed TT1 vector samples. In addition to the RT-qPCR infectivity assay, the stability of the TT1 vector upon freeze-thaw stress was investigated further with complementary viral particle characterization techniques (e.g., TEM, NTA, MFI). Correlations between viral infectivity and particle measurements during forced degradation studies were observed to be specific to the TT1 vector and its various formulations and such results facilitated the rank-ordering of formulation conditions. Overall, this infectivity RT-qPCR method showed increased sample throughput and improved assay flexibility compared to traditional viral infectivity assays. These results are discussed in the context of enabling future TT1 vector formulation development work, and potential utilization as an in-process monitoring tool during TT1 vector manufacturing.</description><subject>Focus forming unit (FFU)</subject><subject>Formulation</subject><subject>Replicating recombinant lymphocytic choriomeningitis virus (TT1)</subject><subject>Reverse transcription quantitative PCR (RT-qPCR)</subject><subject>Stability</subject><subject>Viral vector</subject><issn>0166-0934</issn><issn>1879-0984</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkcuO0zAUhi0EYjoDrzDykk2Kb3GaHahcpUqg0bC2HOe4cZXEwXYi5ZHmLXFphy0rW_L3n0_HP0L3lGwpofL9aXtaXPADpC0jjG4pFUKQF2hDd1VdkHonXqJNBmW-c3GDbmM8EULKivPX6IaLuhScyA16-gQL9H4aYEzYW6xx545dkbrg52M3zQk_PBY_9w-40RFanJ26x260YJJbXFqxjlGv2PqABz-65IMbjzh1gGPSjevPyN-xAabeGZ3OzwGMHxo36uw8rMPUebMmZ_C-y_G805ghl1y86pYs8-ENemV1H-Ht9bxDv758ftx_Kw4_vn7ffzwURlCZipILyVsjGgbWyJpTI7jVtLKUlUwDlECt1juowNKqtBy4qdmukSTHG8Ykv0PvLnOn4H_PEJMaXDTQ93oEP0fFJBVVWZc1y6i8oCb4GANYNQU36LAqStS5JnVSzzWpc03qUlMO3l8dczNA-y_23EsGPlwAyJsuDoKKxsFooHX585Jqvfuf4w9grqxX</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Gupta, Vineet</creator><creator>Antunez, Lorena R.</creator><creator>Saleh-Birdjandi, Soraia</creator><creator>Kumru, Ozan S.</creator><creator>Pospisil, Richard</creator><creator>Lilja, Anders</creator><creator>Fuhrmann, Gerhard</creator><creator>Smith, Lee</creator><creator>Volkin, David B.</creator><creator>Joshi, Sangeeta B.</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3494-550X</orcidid><orcidid>https://orcid.org/0000-0002-1448-1998</orcidid></search><sort><creationdate>202203</creationdate><title>Development of a high-throughput RT-PCR based viral infectivity assay for monitoring the stability of a replicating recombinant Lymphocytic Choriomeningitis viral vector</title><author>Gupta, Vineet ; Antunez, Lorena R. ; Saleh-Birdjandi, Soraia ; Kumru, Ozan S. ; Pospisil, Richard ; Lilja, Anders ; Fuhrmann, Gerhard ; Smith, Lee ; Volkin, David B. ; Joshi, Sangeeta B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-53463dc4b2efc6931c43fa17f1252aee5e1faa8e7ef175f3e3c928b60c41b2263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Focus forming unit (FFU)</topic><topic>Formulation</topic><topic>Replicating recombinant lymphocytic choriomeningitis virus (TT1)</topic><topic>Reverse transcription quantitative PCR (RT-qPCR)</topic><topic>Stability</topic><topic>Viral vector</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gupta, Vineet</creatorcontrib><creatorcontrib>Antunez, Lorena R.</creatorcontrib><creatorcontrib>Saleh-Birdjandi, Soraia</creatorcontrib><creatorcontrib>Kumru, Ozan S.</creatorcontrib><creatorcontrib>Pospisil, Richard</creatorcontrib><creatorcontrib>Lilja, Anders</creatorcontrib><creatorcontrib>Fuhrmann, Gerhard</creatorcontrib><creatorcontrib>Smith, Lee</creatorcontrib><creatorcontrib>Volkin, David B.</creatorcontrib><creatorcontrib>Joshi, Sangeeta B.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of virological methods</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gupta, Vineet</au><au>Antunez, Lorena R.</au><au>Saleh-Birdjandi, Soraia</au><au>Kumru, Ozan S.</au><au>Pospisil, Richard</au><au>Lilja, Anders</au><au>Fuhrmann, Gerhard</au><au>Smith, Lee</au><au>Volkin, David B.</au><au>Joshi, Sangeeta B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of a high-throughput RT-PCR based viral infectivity assay for monitoring the stability of a replicating recombinant Lymphocytic Choriomeningitis viral vector</atitle><jtitle>Journal of virological methods</jtitle><addtitle>J Virol Methods</addtitle><date>2022-03</date><risdate>2022</risdate><volume>301</volume><spage>114440</spage><epage>114440</epage><pages>114440-114440</pages><artnum>114440</artnum><issn>0166-0934</issn><eissn>1879-0984</eissn><abstract>•Development of a RT-qPCR-based infectivity assay for a live, recombinant replicating lymphocytic choriomeningitis virus (LCMV) viral vector.•A high positive correlation between the RT-qPCR and the “gold-standard” infectivity assays.•The infectivity RT-qPCR assay demonstrated increased sample throughput and improved assay flexibility.•The RT-qPCR assay can potentially be utilized as an in-process monitoring tool during LCMV vector manufacturing. Traditional virus infectivity titration methods for lymphocytic choriomeningitis virus (LCMV) are laborious, time-consuming, and low-throughput (e.g., focus forming unit (FFA) assay). In this report, we developed a high-throughput reverse transcription quantitative PCR (RT-qPCR)-based virus infectivity assay for relative quantitation of a live, recombinant replicating LCMV -based viral vector (TT1). This in vitro infectivity assay demonstrated a 4-log linear range for TT1 titer quantitation. A high positive Pearson correlation coefficient value (≥ 0.80) was obtained between the RT-qPCR vs. the “gold-standard” FFU assay when comparing the stability profiles of stressed TT1 vector samples. In addition to the RT-qPCR infectivity assay, the stability of the TT1 vector upon freeze-thaw stress was investigated further with complementary viral particle characterization techniques (e.g., TEM, NTA, MFI). Correlations between viral infectivity and particle measurements during forced degradation studies were observed to be specific to the TT1 vector and its various formulations and such results facilitated the rank-ordering of formulation conditions. Overall, this infectivity RT-qPCR method showed increased sample throughput and improved assay flexibility compared to traditional viral infectivity assays. These results are discussed in the context of enabling future TT1 vector formulation development work, and potential utilization as an in-process monitoring tool during TT1 vector manufacturing.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34954306</pmid><doi>10.1016/j.jviromet.2021.114440</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-3494-550X</orcidid><orcidid>https://orcid.org/0000-0002-1448-1998</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0166-0934
ispartof Journal of virological methods, 2022-03, Vol.301, p.114440-114440, Article 114440
issn 0166-0934
1879-0984
language eng
recordid cdi_proquest_miscellaneous_2614759592
source ScienceDirect Journals (5 years ago - present)
subjects Focus forming unit (FFU)
Formulation
Replicating recombinant lymphocytic choriomeningitis virus (TT1)
Reverse transcription quantitative PCR (RT-qPCR)
Stability
Viral vector
title Development of a high-throughput RT-PCR based viral infectivity assay for monitoring the stability of a replicating recombinant Lymphocytic Choriomeningitis viral vector
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T02%3A47%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20a%20high-throughput%20RT-PCR%20based%20viral%20infectivity%20assay%20for%20monitoring%20the%20stability%20of%20a%20replicating%20recombinant%20Lymphocytic%20Choriomeningitis%20viral%20vector&rft.jtitle=Journal%20of%20virological%20methods&rft.au=Gupta,%20Vineet&rft.date=2022-03&rft.volume=301&rft.spage=114440&rft.epage=114440&rft.pages=114440-114440&rft.artnum=114440&rft.issn=0166-0934&rft.eissn=1879-0984&rft_id=info:doi/10.1016/j.jviromet.2021.114440&rft_dat=%3Cproquest_cross%3E2614759592%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2614759592&rft_id=info:pmid/34954306&rft_els_id=S0166093421003797&rfr_iscdi=true